These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38397992)

  • 21. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps.
    Koski RR; Hill L; Taavola K
    J Pharm Technol; 2022 Oct; 38(5):289-296. PubMed ID: 36046351
    [No Abstract]   [Full Text] [Related]  

  • 22. Real-life effectiveness of dupilumab in chronic rhinosinusitis with nasal polyps. Results from eight Hungarian centres with 12-month follow-up.
    Kiricsi A; Bella Z; Kraxner H; Szaloki T; Fent Z; Liktor B; Huszka J; Laszlo P; Gobol D; Helfferich F; Vaska Z; Piski Z; Juhasz-Loisch L; Horvath B; Galantai G; Krisztin N; Toth L; Bodi A; Matuz M; Lujber L; Hirschberg A
    Rhinology; 2024 Jun; ():. PubMed ID: 38848046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP.
    Cantone E; De Corso E; Ricciardiello F; Di Nola C; Grimaldi G; Allocca V; Motta G
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 35893310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases.
    Canonica GW; Bourdin A; Peters AT; Desrosiers M; Bachert C; Weidinger S; Simpson EL; Daizadeh N; Chen Z; Kamat S; Khan AH; Chao J; Graham NMH; Laws E; Rossi AB; Ardeleanu M; Mannent LP; Amin N; Ortiz B; Deniz Y; Djandji M; Rowe PJ
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1515-1526. PubMed ID: 35259535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies.
    Maspero JF; Bachert C; Martinez FJ; Hanania NA; Ortiz B; Patel N; Mannent LP; Praestgaard A; Pandit-Abid N; Siddiqui S; Hardin M
    J Asthma Allergy; 2023; 16():333-342. PubMed ID: 37026112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab.
    Ledda AG; Costanzo G; Sambugaro G; Caruso C; Bullita M; Di Martino ML; Serra P; Firinu D; Del Giacco S
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.
    Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G
    Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.
    van der Lans RJL; Otten JJ; Adriaensen GFJPM; Hoven DR; Benoist LB; Fokkens WJ; Reitsma S
    Allergy; 2023 Oct; 78(10):2684-2697. PubMed ID: 37394895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dupilumab (Dupixent
    Jansen F; Becker B; Eden JK; Breda PC; Hot A; Oqueka T; Betz CS; Hoffmann AS
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1741-1755. PubMed ID: 36242612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date.
    Kim J; Naclerio R
    Ther Clin Risk Manag; 2020; 16():31-37. PubMed ID: 32158216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
    Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study.
    Santomasi C; Buonamico E; Dragonieri S; Iannuzzi L; Portacci A; Quaranta N; Carpagnano GE
    Acta Biomed; 2023 Feb; 94(1):e2023028. PubMed ID: 36786266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
    De Corso E; Settimi S; Montuori C; Corbò M; Passali GC; Porru DP; Lo Verde S; Spanu C; Penazzi D; Di Bella GA; Nucera E; Bonini M; Paludetti G; Galli J
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps.
    Berger P; Menzies-Gow A; Peters AT; Kuna P; Rabe KF; Altincatal A; Soler X; Pandit-Abid N; Siddiqui S; Jacob-Nara JA; Deniz Y; Rowe PJ
    Ann Allergy Asthma Immunol; 2023 Feb; 130(2):215-224. PubMed ID: 36356712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes.
    Schmale IL; Poulakis A; Abend A; Luitje ME; Man LX
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3203-3210. PubMed ID: 37543087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.
    Fujieda S; Matsune S; Takeno S; Ohta N; Asako M; Bachert C; Inoue T; Takahashi Y; Fujita H; Deniz Y; Rowe P; Ortiz B; Li Y; Mannent LP
    Allergy; 2022 Jan; 77(1):186-196. PubMed ID: 33993501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.
    Mustafa SS; Vadamalai K; Scott B; Ramsey A
    Am J Rhinol Allergy; 2021 May; 35(3):399-407. PubMed ID: 32967430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.
    Galletti C; Ragusa M; Sireci F; Ciodaro F; Barbieri MA; Giunta G; Grigaliute E; Immordino A; Lorusso F; Dispenza F; Freni F; Galletti F; Gallina S; La Mantia I; Galletti B
    Am J Otolaryngol; 2024; 45(1):104106. PubMed ID: 37948824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.